Alex Cazes is a seasoned research scientist specializing in Antibody-Drug Conjugates, currently serving as a Director at AstraZeneca since 2022. Prior to this role, Alex worked at Mitsubishi Tanabe Pharma America as a Research Scientist II, where they led early development projects and managed multifunctional teams. Their extensive background includes post-doctoral positions at UC San Diego Health and Sanford Burnham Prebys Medical Discovery Institute, as well as a PhD in Cancer Genetics from Paris-Sud University. Alex has also contributed to various research initiatives at esteemed institutions such as the University of Cambridge and Fred Hutchinson Cancer Research Center.
This person is not in the org chart
This person is not in any offices